Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients

Tao Sheng Li, Masayuki Kubo, Kazuhiro Ueda, Masanori Murakami, Mako Ohshima, Kobayashi Toshiro, Toshiki Tanaka, Bungo Shirasawa, M. Akihito, Kimikazu Hamano

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background-Therapeutic angiogenesis induced by the implantation of autologous bone marrow-derived cells has been used for the treatment of ischemic diseases. However, as the outcomes of cell implantation obviously vary among patients, it is essential to identify patients that would benefit the most from this treatment. Methods and Results-We collected clinical and laboratory data from 25 patients scheduled to undergo sternotomy for various surgical procedures. Then, we aspirated bone marrow cells from the sternum during the operation and investigated the cell quality in vitro by cultivation, and their angiogenic potency in vivo using an ischemic limb model of mice. The angiogenic potency of bone marrow cells differed among patients. Aging, renal failure, anemia, and high serum levels of triglyceride, C-reactive protein, interleukin-6, and type I collagen cross-linked N-telopeptide (NTX) significantly correlated with poor angiogenic potency of bone marrow cells. We assigned scores to these risk factors, and found a strong correlation between the risk scores of patients and the angiogenic potency of their bone marrow cells (r=-0.883, P

Original languageEnglish
JournalCirculation
Volume120
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Bone Marrow Cells
Sternum
Sternotomy
Interleukin-1
C-Reactive Protein
Renal Insufficiency
Anemia
Interleukin-6
Triglycerides
Collagen
Therapeutics
Extremities
Serum

Keywords

  • Angiogenesis
  • Bone marrow cells
  • Risk factor

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients. / Li, Tao Sheng; Kubo, Masayuki; Ueda, Kazuhiro; Murakami, Masanori; Ohshima, Mako; Toshiro, Kobayashi; Tanaka, Toshiki; Shirasawa, Bungo; Akihito, M.; Hamano, Kimikazu.

In: Circulation, Vol. 120, No. SUPPL. 1, 2009.

Research output: Contribution to journalArticle

Li, TS, Kubo, M, Ueda, K, Murakami, M, Ohshima, M, Toshiro, K, Tanaka, T, Shirasawa, B, Akihito, M & Hamano, K 2009, 'Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients', Circulation, vol. 120, no. SUPPL. 1. https://doi.org/10.1161/CIRCULATIONAHA.108.837039
Li, Tao Sheng ; Kubo, Masayuki ; Ueda, Kazuhiro ; Murakami, Masanori ; Ohshima, Mako ; Toshiro, Kobayashi ; Tanaka, Toshiki ; Shirasawa, Bungo ; Akihito, M. ; Hamano, Kimikazu. / Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients. In: Circulation. 2009 ; Vol. 120, No. SUPPL. 1.
@article{87876acbf8a948949f3f55eabf8bcb30,
title = "Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients",
abstract = "Background-Therapeutic angiogenesis induced by the implantation of autologous bone marrow-derived cells has been used for the treatment of ischemic diseases. However, as the outcomes of cell implantation obviously vary among patients, it is essential to identify patients that would benefit the most from this treatment. Methods and Results-We collected clinical and laboratory data from 25 patients scheduled to undergo sternotomy for various surgical procedures. Then, we aspirated bone marrow cells from the sternum during the operation and investigated the cell quality in vitro by cultivation, and their angiogenic potency in vivo using an ischemic limb model of mice. The angiogenic potency of bone marrow cells differed among patients. Aging, renal failure, anemia, and high serum levels of triglyceride, C-reactive protein, interleukin-6, and type I collagen cross-linked N-telopeptide (NTX) significantly correlated with poor angiogenic potency of bone marrow cells. We assigned scores to these risk factors, and found a strong correlation between the risk scores of patients and the angiogenic potency of their bone marrow cells (r=-0.883, P",
keywords = "Angiogenesis, Bone marrow cells, Risk factor",
author = "Li, {Tao Sheng} and Masayuki Kubo and Kazuhiro Ueda and Masanori Murakami and Mako Ohshima and Kobayashi Toshiro and Toshiki Tanaka and Bungo Shirasawa and M. Akihito and Kimikazu Hamano",
year = "2009",
doi = "10.1161/CIRCULATIONAHA.108.837039",
language = "English",
volume = "120",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients

AU - Li, Tao Sheng

AU - Kubo, Masayuki

AU - Ueda, Kazuhiro

AU - Murakami, Masanori

AU - Ohshima, Mako

AU - Toshiro, Kobayashi

AU - Tanaka, Toshiki

AU - Shirasawa, Bungo

AU - Akihito, M.

AU - Hamano, Kimikazu

PY - 2009

Y1 - 2009

N2 - Background-Therapeutic angiogenesis induced by the implantation of autologous bone marrow-derived cells has been used for the treatment of ischemic diseases. However, as the outcomes of cell implantation obviously vary among patients, it is essential to identify patients that would benefit the most from this treatment. Methods and Results-We collected clinical and laboratory data from 25 patients scheduled to undergo sternotomy for various surgical procedures. Then, we aspirated bone marrow cells from the sternum during the operation and investigated the cell quality in vitro by cultivation, and their angiogenic potency in vivo using an ischemic limb model of mice. The angiogenic potency of bone marrow cells differed among patients. Aging, renal failure, anemia, and high serum levels of triglyceride, C-reactive protein, interleukin-6, and type I collagen cross-linked N-telopeptide (NTX) significantly correlated with poor angiogenic potency of bone marrow cells. We assigned scores to these risk factors, and found a strong correlation between the risk scores of patients and the angiogenic potency of their bone marrow cells (r=-0.883, P

AB - Background-Therapeutic angiogenesis induced by the implantation of autologous bone marrow-derived cells has been used for the treatment of ischemic diseases. However, as the outcomes of cell implantation obviously vary among patients, it is essential to identify patients that would benefit the most from this treatment. Methods and Results-We collected clinical and laboratory data from 25 patients scheduled to undergo sternotomy for various surgical procedures. Then, we aspirated bone marrow cells from the sternum during the operation and investigated the cell quality in vitro by cultivation, and their angiogenic potency in vivo using an ischemic limb model of mice. The angiogenic potency of bone marrow cells differed among patients. Aging, renal failure, anemia, and high serum levels of triglyceride, C-reactive protein, interleukin-6, and type I collagen cross-linked N-telopeptide (NTX) significantly correlated with poor angiogenic potency of bone marrow cells. We assigned scores to these risk factors, and found a strong correlation between the risk scores of patients and the angiogenic potency of their bone marrow cells (r=-0.883, P

KW - Angiogenesis

KW - Bone marrow cells

KW - Risk factor

UR - http://www.scopus.com/inward/record.url?scp=70349783277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349783277&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.108.837039

DO - 10.1161/CIRCULATIONAHA.108.837039

M3 - Article

C2 - 19752376

AN - SCOPUS:70349783277

VL - 120

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - SUPPL. 1

ER -